HK Stock Market Move | PEGBIO CO-B (02565) opened more than 11% higher; core product Paidakang successfully included in the 2026 national medical insurance catalog.
PEGBIO CO-B (02565) opened more than 11% higher. As of press time, it was up 11.54% at HK$3.625, with a turnover of HK$1.9996 million.
PEGBIO CO-B (02565) opened more than 11% higher. As of press time, it was up 11.54% at HK$3.625, with a turnover of HK$1.9996 million.
On the news front, PEGBIO announced that its core self-developed innovative drug product, beinaglutide injection (trade name: Paidakang), has been successfully included in the latest "2026 National Drug Catalog for Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance" published by the National Healthcare Security Administration.
Public information shows that Paidakang is a once-weekly GLP-1 formulation for blood glucose control in adults with type 2 diabetes. Previously, PEGBIO entered into an exclusive commercialization partnership in mainland China with Shanghai Tengrui Pharmaceutical, setting a target of cumulative sales exceeding RMB10 billion, with product sales revenue recognized by PEGBIO. This medical insurance inclusion, combined with the partner's nationwide promotion network, is expected to accelerate the ramp-up of Paidakang and provide key support for the aforementioned commercialization target.
Related Articles

HK Stock Market Move | XUANZHUBIO-B(02575) Rises Over 5% in Early Trading as New Indication for Pyrrolitinib Is Included in the National Basic Medical Insurance Drug Catalog

HK Stock Market Move | GALAXIS TECH (02729) rose nearly 6% in morning trading; the company announced an H-share repurchase plan with a total repurchase amount not exceeding HK$100 million.

HK Stock Market Move | ENVISION GREEN (01783) opens nearly 10% higher; the company has once again locked in GPU supply through a signed agreement and has secured more than 30,000 GPU servers in supply.
HK Stock Market Move | XUANZHUBIO-B(02575) Rises Over 5% in Early Trading as New Indication for Pyrrolitinib Is Included in the National Basic Medical Insurance Drug Catalog

HK Stock Market Move | GALAXIS TECH (02729) rose nearly 6% in morning trading; the company announced an H-share repurchase plan with a total repurchase amount not exceeding HK$100 million.

HK Stock Market Move | ENVISION GREEN (01783) opens nearly 10% higher; the company has once again locked in GPU supply through a signed agreement and has secured more than 30,000 GPU servers in supply.






